Crescent Capital Bdc Stock Net Asset
| CCAP Stock | USD 13.59 0.64 4.50% |
Crescent Capital's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Crescent Stock price.
Crescent | Net Asset | Build AI portfolio with Crescent Stock |
Crescent Capital BDC Company Net Asset Analysis
Crescent Capital's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Crescent Capital Net Asset | 1.66 B |
Most of Crescent Capital's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Crescent Capital BDC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Crescent Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Crescent Capital is extremely important. It helps to project a fair market value of Crescent Stock properly, considering its historical fundamentals such as Net Asset. Since Crescent Capital's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Crescent Capital's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Crescent Capital's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Crescent Total Assets
Total Assets |
|
Based on the recorded statements, Crescent Capital BDC has a Net Asset of 1.66 B. This is much higher than that of the Capital Markets sector and significantly higher than that of the Financials industry. The net asset for all United States stocks is notably lower than that of the firm.
Crescent Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Crescent Capital's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Crescent Capital could also be used in its relative valuation, which is a method of valuing Crescent Capital by comparing valuation metrics of similar companies.Crescent Capital is currently under evaluation in net asset category among its peers.
Crescent Capital Current Valuation Drivers
We derive many important indicators used in calculating different scores of Crescent Capital from analyzing Crescent Capital's financial statements. These drivers represent accounts that assess Crescent Capital's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Crescent Capital's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 403.3M | 501.2M | 394.7M | 624.4M | 712.3M | 747.9M | |
| Enterprise Value | 873.4M | 1.1B | 1.0B | 1.5B | 1.6B | 1.7B |
Crescent Capital ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Crescent Capital's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Crescent Capital's managers, analysts, and investors.Environmental | Governance | Social |
Crescent Capital Institutional Holders
Institutional Holdings refers to the ownership stake in Crescent Capital that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Crescent Capital's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Crescent Capital's value.| Shares | Aspen Grove Capital Llc | 2025-06-30 | 259.6 K | Two Sigma Advisers, Llc | 2025-06-30 | 246.6 K | Wells Fargo & Co | 2025-06-30 | 246 K | Ubs Group Ag | 2025-06-30 | 222 K | Blackrock Inc | 2025-06-30 | 212.3 K | Kovitz Investment Group Partners, Llc | 2025-06-30 | 210.8 K | Denali Advisors Llc | 2025-06-30 | 153.7 K | Hightower Advisors, Llc | 2025-06-30 | 135.7 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 119.2 K | Texas County & District Retirement System | 2025-06-30 | 5 M | Fidelity National Title Group, Inc. | 2025-06-30 | 4.2 M |
Crescent Fundamentals
| Return On Equity | 0.0598 | ||||
| Return On Asset | 0.0527 | ||||
| Profit Margin | 0.24 % | ||||
| Operating Margin | 0.75 % | ||||
| Current Valuation | 1.38 B | ||||
| Shares Outstanding | 37.04 M | ||||
| Shares Owned By Insiders | 3.26 % | ||||
| Shares Owned By Institutions | 66.40 % | ||||
| Number Of Shares Shorted | 265.04 K | ||||
| Price To Earning | 3.78 X | ||||
| Price To Book | 0.73 X | ||||
| Price To Sales | 2.75 X | ||||
| Revenue | 194.85 M | ||||
| Gross Profit | 183.17 M | ||||
| EBITDA | 138.67 M | ||||
| Net Income | 73.65 M | ||||
| Cash And Equivalents | 9.41 M | ||||
| Cash Per Share | 0.31 X | ||||
| Total Debt | 875.84 M | ||||
| Debt To Equity | 1.02 % | ||||
| Current Ratio | 1.14 X | ||||
| Book Value Per Share | 19.55 X | ||||
| Cash Flow From Operations | 58.91 M | ||||
| Short Ratio | 1.11 X | ||||
| Earnings Per Share | 0.97 X | ||||
| Price To Earnings To Growth | 0.89 X | ||||
| Target Price | 17.08 | ||||
| Beta | 0.58 | ||||
| Market Capitalization | 503.37 M | ||||
| Total Asset | 1.66 B | ||||
| Retained Earnings | (218.5 M) | ||||
| Annual Yield | 0.12 % | ||||
| Net Asset | 1.66 B | ||||
| Last Dividend Paid | 1.68 |
About Crescent Capital Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Crescent Capital BDC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Crescent Capital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Crescent Capital BDC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Crescent Capital
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Crescent Capital position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescent Capital will appreciate offsetting losses from the drop in the long position's value.Moving together with Crescent Stock
Moving against Crescent Stock
| 0.69 | BIOG | Biotech Growth | PairCorr |
| 0.66 | LWI | Lowland Investment | PairCorr |
| 0.65 | IEM | Impax Environmental | PairCorr |
| 0.58 | ATT | Allianz Technology Trust | PairCorr |
| 0.57 | HRI | Herald Investment Trust | PairCorr |
The ability to find closely correlated positions to Crescent Capital could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Crescent Capital when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Crescent Capital - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Crescent Capital BDC to buy it.
The correlation of Crescent Capital is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Crescent Capital moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Crescent Capital BDC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Crescent Capital can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Crescent Stock Analysis
When running Crescent Capital's price analysis, check to measure Crescent Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescent Capital is operating at the current time. Most of Crescent Capital's value examination focuses on studying past and present price action to predict the probability of Crescent Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescent Capital's price. Additionally, you may evaluate how the addition of Crescent Capital to your portfolios can decrease your overall portfolio volatility.